In:
Cancer, Wiley, Vol. 119, No. 10 ( 2013-05-15), p. 1838-1844
Abstract:
This prospective study demonstrates that plasma Epstein‐Barr virus DNA is detectable in patients who have early stage nasopharyngeal carcinoma. The results indicate that it is feasible to use plasma Epstein‐Barr virus DNA as surveillance for nasopharyngeal carcinoma in asymptomatic individuals.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v119.10
Language:
English
Publisher:
Wiley
Publication Date:
2013
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
1429-1